(VIANEWS) – The NYSE opens in less than two hours and West Pharmaceutical‘s pre-market value is already 9.34% down.
West Pharmaceutical’s last close was $378.33, 2.27% under its 52-week high of $387.13.
The last session, NYSE ended with West Pharmaceutical (WST) dropping 1.08% to $378.33. NYSE rose 0.27% to $15,918.50, after three sequential sessions in a row of gains, on what was a somewhat up trend exchanging session.
About West Pharmaceutical
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. The company was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
Earnings Per Share
As for profitability, West Pharmaceutical has a trailing twelve months EPS of $7.28.
PE Ratio
West Pharmaceutical has a trailing twelve months price to earnings ratio of 51.97. Meaning, the purchaser of the share is investing $51.97 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.64%.
More news about West Pharmaceutical (WST).
